NKCFO LLC’s PetMed Express PETS Stock Holding History

NKCFO LLC’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,200	Closed	-$133K	–	126
2020 Q3	$133K	Buy	+4,200	New	+$139K	0.06%	67

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

NKCFO LLC's PETS Position: Q4 2020 in Review

NKCFO LLC sold out of PetMed Express (PETS) in Q4 2020, closing a stake of 4,200 shares — an estimated $133K sold.

NKCFO LLC first reported a position in PETS in Q3 2020 and held it in 1 quarter. The position peaked at $133K in Q3 2020. 213 funds tracked by Wall St. Rank hold PETS as of Q4 2020.

NKCFO LLC reported no remaining PetMed Express position as of Q4 2020 after selling out during the quarter.
NKCFO LLC sold 4,200 PetMed Express shares in Q4 2020, an estimated $133K.
NKCFO LLC first reported a position in PetMed Express in Q3 2020 and held it in 1 quarter.
NKCFO LLC's PetMed Express position peaked at $133K in Q3 2020.
213 funds tracked by Wall St. Rank held PetMed Express as of Q4 2020.

Based on NKCFO LLC's 13F filing for Q4 2020, filed 28 Jan 2021.